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The following historical review summarizes an important
article on perfusion imaging originally published in JACC in
September 1995. This article contributed to the greater
understanding of the diagnostic and prognostic applications
of exercise myocardial perfusion in patients with suspected
or known coronary artery disease.
Incremental Value of Prognostic Testing
in Patients With Known or Suspected
Ischemic Heart Disease: A Basis for
Optimal Utilization of Exercise
Technetium-99m Sestamibi Myocardial
Perfusion Single-Photon Emission
Computed Tomography
by D. S. Berman, R. Hachamovitch, H. Kiat, I. Cohen,
J. A. Cabico, F. P. Wang, J. D. Friedman, G. Germano,
K. Van Train, G. A. Diamond (1)
ABSTRACT
A cohort of 1,702 patients was referred for exercise 99mTc-
sestamibi single-photon emission computed tomography
(SPECT) from January 1, 1991, to January 1, 1993, for whom
follow-up could be obtained. Patients were followed for 20 6 5
months. Of the 1,131 who had normal or equivocal scan results,
1 cardiac death and 1 myocardial infarction occurred (0.2%
event rate), and 17 cardiac deaths and 26 nonfatal infarctions
were reported in the 571 patients with abnormal scans (7.5%
event rate). This low event rate in patients with normal or
near-normal scans was similar in patients with a low (,0.15),
intermediate (0.15 to 0.85) and high (.0.85) postexercise
treadmill test (ETT) likelihood of coronary artery disease
(CAD). In contrast, if the scan was abnormal, the hard cardiac
event rates were 3.8%, 7.9% and 10.8% in these three groups,
respectively. There were 1,282 patients with interpretable
exercise electrocardiogram responses, of whom 231 were judged
to have ,15% post-ETT likelihood of CAD. The SPECT had
incremental prognostic value in these patients, in that 167 had
a normal scan with a 0% event rate and 64 had an abnormal
scan with a 6.2% event rate. Of the 503 patients with an
intermediate or high post-ETT likelihood of CAD, SPECT also
provided incremental prognostic value in the 274 patients with
a normal scan who had a 0% event rate, whereas the 229
patients with an abnormal scan had a 7.9% event rate. Risk
stratification was also significantly enhanced in the 420 patients
with uninterpretable ETT results. No events occurred in those
with a normal scan. Finally, the nuclear scan strategy was
shown to be cost-effective in patients with intermediate-to-high
post-ETT likelihood of CAD if only patients with abnormal
scans are referred to catheterization.
Originally published in the Journal of the American College of Cardiology,
September 1995.
From the University of Virginia School of Medicine, Charlottesville, Virginia.
50th Anniversary Historical Article
INTRODUCTION
In this edition of the Journal, we release the eighth in a series
of reviews of influential articles that have been previously
published in ACC journals, including the American Journal of
Cardiology (from 1958 to 1982) and JACC (from 1983 to the
present). The publication of these articles is only one aspect of the
ACC’s 50th anniversary commemoration, which highlights 50
years of leadership in cardiovascular care and education. The
articles are intended to encourage reflection on the remarkable
progress made in cardiovascular medicine over time, as well as to
acknowledge the amazing prescience of some early investigators in
anticipating and, in many cases, later guiding developments in
their field.
The working group responsible for selecting these articles and
asking reviewers to write editorials solicited suggestions from
the ACC’s clinical committees and individual members.
The group achieved consensus fairly easily, including whom the
group should ask to prepare the accompanying editorials. We
initially drew up a list of 14 general areas to cover in this series,
but later found that there are several major areas of modern
cardiology, prominently molecular cardiology, in which the truly
landmark articles have, alas, not yet been published in JACC.
Therefore, the working group decided not to categorize by subject,
but instead, to concentrate on the most important articles.
The working group, a task force of the Subcommittee for the
Commemoration of the ACC 50th Anniversary, owes a great
deal to Ms. May A. Roustom and the efficient and tireless staff
at Heart House for facilitating this project. We also wish to
thank all who suggested articles and, most important, the
authors who prepared reviews for their willingness to contribute
their time and wisdom.
Influential Articles in JACC Working Group
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Review
Historical perspective. The Cedars-Sinai group has made
major contributions to furthering the understanding of the
diagnostic and prognostic applications of exercise or phar-
macologic stress myocardial perfusion in patients with
suspected or known coronary artery disease (CAD). In two
studies published in 1986 and 1987, Dr. Berman et al. (1)
showed the extent and severity of exercise-induced 201T1
defects on planar images were independent predictors of
future cardiac events (2,3). These reports comprised the
largest number of patients ever studied up to that time
regarding the assessment of the prognostic value of a
noninvasive imaging technique, and the study by Laden-
heim et al. (3) was the first to demonstrate the incremental
prognostic power of clinical variables, exercise electrocar-
diographic (ECG) stress test variables and myocardial
perfusion imaging data. They extended the important initial
observations of Brown et al. (4), who showed that the
number of reversible 201T1 defects on stress scintigrams was
the best predictor of death and nonfatal infarction in 100
patients without prior infarction who underwent exercise
planar 201T1 scintigraphy. Using stepwise logistic regression
analysis, Ladenheim et al. (3) identified the number of
myocardial scan segments with reversible 201T1 defects and
the exercise heart rate as the only independent predictors of
subsequent events in 1,689 CAD patients without prior
infarction. Other investigators confirmed or extended these
findings (5–7), and collectively, these studies published in
the 1980s showed that patients with normal perfusion scans
had a ,1% per year cardiac death or nonfatal infarction rate,
whereas those with abnormal scans, particularly those show-
ing a multivessel disease pattern, increased lung 201T1
uptake or transient ischemic left ventricular cavity dilation
had a significantly higher event rate.
Prognostic value of 99mTc-sestamibi SPECT. For many
years, planar and single-photon emission computed tomog-
raphy (SPECT) with 201T1 constituted the only scinti-
graphic technique available for detecting CAD and deter-
mining prognosis. The major limitation of 201T1
scintigraphy is a high false-positive rate for CAD detection
experienced in many laboratories, which is predominantly
attributed to image attenuation artifacts (8). In the past
decade, new 99mTc-labeled perfusion imaging agents were
introduced to clinical practice that provided image quality
superior to that achieved with 201T1 because of the more
favorable physical characteristics of 99mTc for imaging with
a SPECT camera. Sensitivity for CAD detection was
comparable for 99mTc-sestamibi and 201T1 images, but
99mTc-sestamibi yielded enhanced specificity. The Berman
article demonstrated the incremental value for determining
prognosis over clinical and exercise treadmill test (ETT)
data utilizing a dual-imaging protocol (rest 201T1/exercise
99mTc-sestamibi) in 1,702 patients who were followed after
testing for 20 6 5 months. In this study, patients were
divided into low, intermediate and high pretest likelihood of
CAD on the basis of clinical and exercise ECG stress test
data. 99mTc-sestamibi scan results further separated patients
into lower and higher risk subgroups. One very important
finding in this landmark study was that the cardiac event
rate for patients with normal scans was low for all levels of
prescan likelihood of CAD. For example, of the 90 patients
who were classified as having a .85% likelihood of CAD
after the ETT, and who had a normal scan, none had a
cardiac event during follow-up. Thus, the cardiac event rate
in patients with a normal 99mTc-sestamibi SPECT study
was very low, even when clinical and exercise stress test
variables suggested a high risk of CAD. The rates of referral
to catheterization after 99mTc-sestamibi SPECT imaging
were also low in patients with normal perfusion studies,
even if they had a high likelihood of CAD when analyzing
only the clinical and ETT results.
The Berman study was one of the first to provide data
concerning the cost benefit of nuclear testing. The nuclear
scan was cost-effective in patients with interpretable exercise
ECG responses and an intermediate-to-high post-ETT
likelihood of CAD and in those with uninterpretable
exercise ECG responses and an intermediate-to-high pre-
ETT likelihood of CAD. In contrast, nuclear testing was
not cost-effective in patients who had a low likelihood of
having CAD after ETT. Going directly to catheterization
based on the ETT alone cost $2,089 per patient as com-
pared with $1,729 per patient when only patients with
abnormal nuclear scan results were referred to catheteriza-
tion.
Subsequent prognostic studies. After the publication of
the Berman study, the Cedars-Sinai group continued to
evaluate the prognostic value of exercise SPECT. In a study
by Hachamovitch et al. (9), nuclear testing was found to add
significant incremental prognostic value to the Duke tread-
mill score for risk assessment. There were 834 patients
classified as having an intermediate risk of subsequent death
infarction on the basis of the Duke treadmill score who had
a normal scan. The subsequent hard event rate was 0.4%
during follow-up of this group. Multiple logistic regression
analysis revealed that scan information from 99mTc-
sestamibi SPECT contributed 95% of all the information
regarding referral to catheterization. In another publication
by Hachamovitch et al. (10), the Cedars-Sinai group re-
ported that during exercise 99mTc-sestamibi SPECT pro-
vided incremental prognostic value for both men and
women. In fact, receiver operating characteristic (ROC)
analysis demonstrated superior discrimination for the nu-
clear scan results in identifying high-risk women than men
(area under curve: 0.84 in women vs. 0.71 in men; p ,
0.0005). In that study, the odds ratio comparing events of
patients with abnormal scan results versus those with
normal scan results was greater in women than in men,
suggesting superior stratification using SPECT imaging in
women. When added to the clinical and exercise model in a
Cox proportional hazards analysis, nuclear data provided
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17% more prognostic information in men and 37% more in
women when compared with clinical and exercise variables
alone. That study comprised 2,742 men and 1,394 women
who underwent the dual-isotope SPECT protocol and were
followed for an average of 20 6 5 months.
The Cedars-Sinai group went on to demonstrate in a
retrospective analysis of their patient cohort that the results
of SPECT imaging might assist in deciding which patients
with abnormal scans would do well with medical therapy
compared with early revascularization (11). They found that
the annual cardiac death rate was only 0.8% in patients with
mildly abnormal stress perfusion scans who received medical
treatment after testing compared with an annual death rate
of 0.9% in patients with a mildly abnormal scan who
underwent early revascularization after testing. In contrast,
patients with moderately abnormal and severely abnormal
scans (more extensive defects) benefited from revasculariza-
tion early after nuclear testing.
Finally, the Cedars-Sinai group, in conjunction with
several other institutions, prospectively enrolled 11,372
consecutive stable chest pain patients who had been referred
for stress myocardial perfusion imaging or cardiac catheter-
ization (12). The stress imaging patients and the direct
catheterization patients were matched by their pretest clin-
ical risk of CAD (low, intermediate and high). The com-
posite three-year cost of care for the two management
strategies was compiled. These strategies were an initial
stress perfusion SPECT with selective catheterization of
high-risk patients (clinically high risk and those with
ischemia on SPECT) or direct catheterization as the initial
diagnostic approach to diagnosing CAD. The investigators
found that diagnostic and follow-up costs of care were 30%
to 41% higher for the patients undergoing direct catheter-
ization in all pretest clinical risk subsets. The costs for the
direct cardiac catheterization strategy ranged from $2,878 to
$4,579 compared with $2,387 to $3,010 (p , 0.001) for the
stress perfusion imaging plus selective catheterization strat-
egy.
Influence on the field. These clinical observational studies
reported by Berman et al. (1)—describing the supplemen-
tary diagnostic and prognostic value, as well as the cost-
effectiveness, of stress myocardial perfusion imaging over
clinical and exercise ECG stress test data in large numbers
of men and women with suspected or known CAD—have
had a great influence on the area of clinical decision making.
Risk stratification and management strategies were devel-
oped based on studies in which known outcome was linked
to noninvasive imaging variables, such as the extent of
stress-induced hypoperfusion. The concept has thus
emerged that stress myocardial perfusion imaging may
function as a “gatekeeper” for referral for invasive strategies
because it may identify low-risk groups who have an
excellent prognosis treated with medical therapy and do not
benefit from early revascularization. Conversely, the identi-
fication of high-risk patients who would most likely benefit
from early revascularization on the basis of an expected high
cardiac event rate with medical treatment can also be
accomplished. This management approach, in which refer-
ral for cardiac catheterization is ischemia driven, is also
highly cost-effective.
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